Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

Published:2014-10-23 Issue:9 Volume:136 Page:2158-2165
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Madic Jordan¹²,Kiialainen Anna³,Bidard Francois-Clement¹⁴,Birzele Fabian³,Ramey Guillemette⁵,Leroy Quentin⁶,Frio Thomas Rio⁶,Vaucher Isabelle¹,Raynal Virginie²,Bernard Virginie⁶,Lermine Alban⁷,Clausen Inga³,Giroud Nicolas³,Schmucki Roland³,Milder Maud¹⁸,Horn Carsten³,Spleiss Olivia³,Lantz Olivier⁸⁹¹⁰,Stern Marc-Henri²⁹,Pierga Jean-Yves¹⁴¹¹,Weisser Martin¹²,Lebofsky Ronald¹

Affiliation:

1. Laboratory of Circulating Tumor Biomarkers, SIRIC, Institut Curie; Paris France

2. Inserm U830; Paris France

3. Roche Pharma Research and Early Development (pRED), Roche Innovation Center; Basel Switzerland

4. Department of Medical Oncology; Institut Curie; Paris France

5. Institut Roche de Recherche et Médecine Translationnelle; Boulogne-Billancourt Paris France

6. NGS Platform, ICGex, Institut Curie; Paris France

7. Inserm U900; Paris France

8. Inserm CIC BT-507; Paris France

9. Department of Tumor Biology; Institut Curie; Paris France

10. Inserm U932; Paris France

11. University Paris Descartes; Paris France

12. Roche Pharma Research and Early Development (pRED); Roche Innovation Center; Penzberg Germany

Funder

Roche

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies;Blows;PLoS Med,2010

2. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

3. The clonal and mutational evolution spectrum of primary triple-negative breast cancers;Shah;Nature,2012

4. Going with the flow: from circulating tumor cells to DNA;Bidard;Sci Transl Med,2013

5. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data;Bidard;Lancet Oncol,2014

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer;Critical Reviews in Oncology/Hematology;2024-09

2. Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA;Clinical Cancer Research;2024-06-03

3. Research History, Current Trends, and Future Prospects of Liquid Biopsy in Triple-Negative Breast Cancer: An Analysis from a Global Perspective;2024-04-05

4. Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer;Translational Breast Cancer Research;2024-04

5. Metastatic progression of breast cancer along with decreased mitochondrial cell death priming of breast cancer cells: a case report;Oxford Medical Case Reports;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3